AU2010325147B2 - Detection of intraamniotic infection - Google Patents

Detection of intraamniotic infection Download PDF

Info

Publication number
AU2010325147B2
AU2010325147B2 AU2010325147A AU2010325147A AU2010325147B2 AU 2010325147 B2 AU2010325147 B2 AU 2010325147B2 AU 2010325147 A AU2010325147 A AU 2010325147A AU 2010325147 A AU2010325147 A AU 2010325147A AU 2010325147 B2 AU2010325147 B2 AU 2010325147B2
Authority
AU
Australia
Prior art keywords
cervical
intra
infection
afp
amniotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2010325147A
Other languages
English (en)
Other versions
AU2010325147A1 (en
AU2010325147A2 (en
Inventor
Thomas H. Grove
Elizabeth Inman Laderman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hologic Inc
Original Assignee
Hologic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hologic Inc filed Critical Hologic Inc
Publication of AU2010325147A1 publication Critical patent/AU2010325147A1/en
Publication of AU2010325147A2 publication Critical patent/AU2010325147A2/en
Application granted granted Critical
Publication of AU2010325147B2 publication Critical patent/AU2010325147B2/en
Priority to AU2016234932A priority Critical patent/AU2016234932B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56933—Mycoplasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5412—IL-6
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2010325147A 2009-11-25 2010-11-22 Detection of intraamniotic infection Active AU2010325147B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016234932A AU2016234932B2 (en) 2009-11-25 2016-09-28 Detection of intraamniotic infection

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26463309P 2009-11-25 2009-11-25
US61/264,633 2009-11-25
US36219210P 2010-07-07 2010-07-07
US61/362,192 2010-07-07
PCT/US2010/003052 WO2011065976A1 (en) 2009-11-25 2010-11-22 Detection of intraamniotic infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016234932A Division AU2016234932B2 (en) 2009-11-25 2016-09-28 Detection of intraamniotic infection

Publications (3)

Publication Number Publication Date
AU2010325147A1 AU2010325147A1 (en) 2012-07-19
AU2010325147A2 AU2010325147A2 (en) 2012-11-08
AU2010325147B2 true AU2010325147B2 (en) 2016-06-30

Family

ID=43769725

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2010325147A Active AU2010325147B2 (en) 2009-11-25 2010-11-22 Detection of intraamniotic infection
AU2016234932A Active AU2016234932B2 (en) 2009-11-25 2016-09-28 Detection of intraamniotic infection

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2016234932A Active AU2016234932B2 (en) 2009-11-25 2016-09-28 Detection of intraamniotic infection

Country Status (8)

Country Link
US (3) US8663576B2 (enExample)
EP (1) EP2504706B1 (enExample)
JP (2) JP5781530B2 (enExample)
CN (1) CN102667486B (enExample)
AU (2) AU2010325147B2 (enExample)
CA (1) CA2780976C (enExample)
ES (1) ES2677944T3 (enExample)
WO (1) WO2011065976A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8663576B2 (en) * 2009-11-25 2014-03-04 Hologic, Inc. Detection of intraamniotic infection
KR101142434B1 (ko) * 2011-09-08 2012-05-08 (주)오비메드 조기양막파수 산모에서 비침습적인 양수 내 염증 및 감염의 예측 또는 진단 방법
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
EP2912458B1 (en) 2012-10-24 2018-07-18 NYU Winthrop Hospital Non-invasive biomarker to identify subjects at risk of preterm delivery
CA2935960C (en) 2014-01-08 2023-01-10 Bart Lipkens Acoustophoresis device with dual acoustophoretic chamber
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
CN107045063B (zh) * 2016-02-06 2019-01-25 华中农业大学 肺结核相关血清标识蛋白timp-1及其应用
FR3048287B1 (fr) * 2016-02-26 2018-03-23 Biosynex Procede de detection d'accouchement imminent
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
WO2018030270A1 (ja) * 2016-08-09 2018-02-15 公立大学法人横浜市立大学 川崎病の検査方法および試験片
US20200264188A1 (en) 2017-09-13 2020-08-20 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
KR20220066413A (ko) 2017-12-14 2022-05-24 프로디자인 소닉스, 인크. 음향 트랜스듀서 구동기 및 제어기
WO2019238893A1 (en) * 2018-06-14 2019-12-19 Universite de Bordeaux Treatment of placental chronic histiocytic intervillositis using an inhibitor of interleukin-1
CN108896769B (zh) * 2018-08-08 2020-05-22 福建医科大学 基于金纳米团簇的人β2-微球蛋白检测方法及其试剂盒
JP7175158B2 (ja) * 2018-10-29 2022-11-18 アークレイ株式会社 情報処理装置、測定システム、及びプログラム
CN111269871B (zh) * 2018-12-05 2023-06-13 中国科学院大连化学物理研究所 一种基于羊膜芯片的宫内感染模型建立方法
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
RU2744680C1 (ru) * 2020-06-16 2021-03-15 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр имени В.А. Алмазова" Министерства здравоохранения Российской Федерации Способ прогнозирования развития послеродового эндометрита
CN112485446A (zh) * 2020-11-18 2021-03-12 重庆中元汇吉生物技术有限公司 一种测定全量程c反应蛋白的试剂盒及其制备方法
WO2022254239A1 (en) * 2021-06-01 2022-12-08 University Of Hong Kong Fibrosis biomarkers for non-alcoholic fatty liver disease
US20250120681A1 (en) * 2021-08-26 2025-04-17 Mor Research Applications Ltd. Apparatus and method for the diagnosis of vulvovaginal conditions
CA3241918A1 (en) * 2022-01-31 2023-08-03 Hector Han-Li HUANG Biomarkers for diagnosing preeclampsia
CN117647645B (zh) * 2024-01-29 2024-04-12 中国人民解放军总医院第一医学中心 Lbp、atf6、m-csfr联用在制备诊断自身免疫性肝病产品中的应用及试剂盒

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070161125A1 (en) * 2003-03-25 2007-07-12 Ron Rosenfeld Proteomic analysis of biological fluids
WO2008057160A2 (en) * 2006-10-06 2008-05-15 Nestec S.A. Compositions and multiplex assays for measuring biological mediators of physiological health

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4094647A (en) 1976-07-02 1978-06-13 Thyroid Diagnostics, Inc. Test device
US4235601A (en) 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
US4361537A (en) 1979-01-12 1982-11-30 Thyroid Diagnostics, Inc. Test device and method for its use
GB8331514D0 (en) 1983-11-25 1984-01-04 Janssen Pharmaceutica Nv Visualization method
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
US4857453A (en) 1987-04-07 1989-08-15 Syntex (U.S.A.) Inc. Immunoassay device
US4855240A (en) 1987-05-13 1989-08-08 Becton Dickinson And Company Solid phase assay employing capillary flow
US4943522A (en) 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US6283761B1 (en) 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
US6008056A (en) * 1997-05-28 1999-12-28 Epitope, Inc. Sample volume control for lateral flow chromatography
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
FR2809182B1 (fr) * 2000-05-18 2003-08-15 Univ Rene Descartes Detection de l'il-6 pour la prevision des risques d'accouchement premature
EP1590664A4 (en) 2003-02-05 2007-05-23 Ciphergen Biosystems Inc NON-INVASIVE ASSESSMENT OF THE INTRA-NAMINE ENVIRONMENT
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US7790463B2 (en) * 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
WO2007124439A2 (en) * 2006-04-21 2007-11-01 Rules-Based Medicine, Inc. Diagnosis of stroke using metalloproteinase or transaminase
GB0722729D0 (en) * 2007-11-20 2007-12-27 Bristol Myers Squibb Co Diagnostic markers of wound infection
CN101221180B (zh) * 2008-01-25 2011-11-30 马义才 一种便携式多种肿瘤标志物快速联检装置
US8663576B2 (en) * 2009-11-25 2014-03-04 Hologic, Inc. Detection of intraamniotic infection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070161125A1 (en) * 2003-03-25 2007-07-12 Ron Rosenfeld Proteomic analysis of biological fluids
WO2008057160A2 (en) * 2006-10-06 2008-05-15 Nestec S.A. Compositions and multiplex assays for measuring biological mediators of physiological health

Also Published As

Publication number Publication date
US20110184254A1 (en) 2011-07-28
US20160077101A1 (en) 2016-03-17
CN102667486B (zh) 2016-03-09
AU2010325147A1 (en) 2012-07-19
CA2780976A1 (en) 2011-06-03
CN102667486A (zh) 2012-09-12
US20140154714A1 (en) 2014-06-05
JP2013512434A (ja) 2013-04-11
US9164092B2 (en) 2015-10-20
WO2011065976A1 (en) 2011-06-03
AU2016234932B2 (en) 2017-11-23
EP2504706A1 (en) 2012-10-03
JP5781530B2 (ja) 2015-09-24
EP2504706B1 (en) 2018-05-23
CA2780976C (en) 2020-03-31
AU2016234932A1 (en) 2016-10-20
AU2010325147A2 (en) 2012-11-08
US10215760B2 (en) 2019-02-26
JP6173387B2 (ja) 2017-08-02
ES2677944T3 (es) 2018-08-07
JP2015232567A (ja) 2015-12-24
US8663576B2 (en) 2014-03-04

Similar Documents

Publication Publication Date Title
AU2016234932B2 (en) Detection of intraamniotic infection
US8068990B2 (en) Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
JP5011410B2 (ja) 生体液のプロテオーム分析
US20100017143A1 (en) Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
US20110015087A1 (en) Detection of endometrial secretion markers for assessment of endometriosis
JP2006524331A5 (enExample)
US20100029006A1 (en) Multiplexed diagnostic test for preterm labor
CN101680884A (zh) 检测先兆子痫的方法
Buhimschi et al. Proteomics/diagnosis of chorioamnionitis and of relationships with the fetal exposome
HK1173775B (en) Detection of intraamniotic infection
HK1173775A (en) Detection of intraamniotic infection

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 22 JUN 2012 .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 22 JUN 2012

FGA Letters patent sealed or granted (standard patent)